IL6 and cancer: Our results are in agreement with findings of a recent study by Kvarnsrtom et al.[26], who observed a similar increase in IL-6 levels in the peri-operative period in cancer patients undergoing major abdominal surgery who were randomized to receive either propofol-remifentanil or sevoflurane-fentanyl.